Experimental Heart-Lung machine offers lifeline to dying patients awaiting transplant
NCT ID NCT06770023
Summary
This small, early-stage study is testing whether a specialized heart-lung bypass machine can safely keep critically ill patients with severe pulmonary hypertension and heart failure alive long enough to receive a lung transplant. The device is inserted through a vein and is designed to support the failing right side of the heart. Researchers will closely monitor four patients to see if they survive to transplant and track serious complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Florida
RECRUITINGJacksonville, Florida, 32224, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.